Evidence shows its involvement in promoting mammary tumor growth and metastasis in mice as well as its activation in hepatocellular carcinoma under hypoxic conditions, both through BCL9/BCL9L and Wnt pathway activation [73,74]. The gene discussed is BCL9L; the disease is hepatocellular carcinoma.